Abstract
In this issue of Blood, Marlein et al1 identify a tumor-specific NOX2-dependent transfer of mitochondria from bone marrow stromal cells (BMSCs) to acute myeloid leukemia (AML) cells via AML-derived tunneling nanotubes (see figure), supporting inhibition of NOX2 as a novel therapeutic strategy in AML.
| Original language | English |
|---|---|
| Pages (from-to) | 1603-1604 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 130 |
| Issue number | 14 |
| DOIs |
|
| State | Published - Oct 5 2017 |
Fingerprint
Dive into the research topics of 'Mitochondria on the move: BMSCs fuel AML energy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver